InfuSystem to Participate in Lytham Partners Fall 2024 Investor Conference on October 1, 2024
InfuSystem Holdings, Inc. (NYSE American: INFU) announced its participation in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024. Key executives, including CEO Richard DiIorio, President and COO Carrie Lachance, and CFO Barry Steele, will be present. A webcasted fireside chat with DiIorio is scheduled for 3:30pm ET.
The webcast will be accessible via the conference website and InfuSystem's investor relations page. Management will be available for one-on-one and group meetings with investors. InfuSystem is a leading national health care service provider operating under two platforms: Patient Services and Device Solutions. The company facilitates outpatient care for durable medical equipment manufacturers and health care providers, with a focus on oncology, pain management, and wound therapy.
InfuSystem Holdings, Inc. (NYSE American: INFU) ha annunciato la sua partecipazione alla Conferenza sugli Investitori Lytham Partners Fall 2024 il 1° ottobre 2024. Saranno presenti i principali dirigenti, tra cui il CEO Richard DiIorio, il Presidente e COO Carrie Lachance e il CFO Barry Steele. Un chat informale in streaming con DiIorio è programmata per le 15:30 ET.
La trasmissione sarà accessibile tramite il sito web della conferenza e la pagina delle relazioni con gli investitori di InfuSystem. La direzione sarà disponibile per incontri individuali e di gruppo con gli investitori. InfuSystem è un fornitore di servizi sanitari nazionale leader, che opera su due piattaforme: Servizi per i Pazienti e Soluzioni per Dispositivi. L'azienda facilita l'assistenza ambulatoriale per i produttori di attrezzature mediche durevoli e i fornitori di servizi sanitari, con un focus su oncologia, gestione del dolore e terapia delle ferite.
InfuSystem Holdings, Inc. (NYSE American: INFU) anunció su participación en la Conferencia de Inversores Lytham Partners Fall 2024 el 1 de octubre de 2024. Asistirán ejecutivos clave, incluido el CEO Richard DiIorio, la presidenta y COO Carrie Lachance, y el CFO Barry Steele. Se ha programado un charlas informales transmitidas por webcast con DiIorio a las 3:30 p.m. ET.
La transmisión estará disponible a través del sitio web de la conferencia y la página de relaciones con inversores de InfuSystem. La dirección estará disponible para reuniones individuales y grupales con los inversores. InfuSystem es un proveedor nacional líder de servicios de salud que opera en dos plataformas: Servicios al Paciente y Soluciones para Dispositivos. La empresa facilita la atención ambulatoria para fabricantes de equipos médicos duraderos y proveedores de salud, con un enfoque en oncología, manejo del dolor y terapia de heridas.
InfuSystem Holdings, Inc. (NYSE American: INFU)는 2024년 10월 1일에 열리는 Lytham Partners Fall 2024 투자자 회의에 참여할 것이라고 발표했습니다. CEO 리차드 디리오리(Richard DiIorio), 사장 겸 COO 캐리 라샨스(Carrie Lachance), CFO 배리 스틸(Barry Steele)을 포함한 주요 임원들이 참석할 예정입니다. 디리오리와의 웹캐스트 소규모 대화는 오후 3시 30분 ET로 예정되어 있습니다.
웹캐스트는 회의 웹사이트와 InfuSystem의 투자자 관계 페이지를 통해 접근할 수 있습니다. 경영진은 투자자와의 1:1 및 그룹 미팅을 위해 대기할 것입니다. InfuSystem은 환자 서비스와 장치 솔루션의 두 가지 플랫폼 아래에서 운영되는 선도적인 국가 의료 서비스 제공업체입니다. 이 회사는 내구성 있는 의료 장비 제조업체 및 의료 제공자를 위한 외래 환자 치료를 지원하며, 암 치료, 통증 관리 및 상처 치료에 중점을 두고 있습니다.
InfuSystem Holdings, Inc. (NYSE American: INFU) a annoncé sa participation à la Conférence des investisseurs Lytham Partners Fall 2024 le 1er octobre 2024. Des dirigeants clés, y compris le PDG Richard DiIorio, la présidente et COO Carrie Lachance, ainsi que le CFO Barry Steele, seront présents. Un discussion informelle diffusée en direct avec DiIorio est prévue à 15h30 ET.
Le webcast sera accessible via le site de la conférence et la page des relations avec les investisseurs d'InfuSystem. La direction sera disponible pour des réunions individuelles et en groupe avec les investisseurs. InfuSystem est un leader national des services de santé opérant sur deux plateformes : Services aux patients et Solutions de dispositifs. L'entreprise facilite les soins ambulatoires pour les fabricants d'équipements médicaux durables et les prestataires de soins de santé, avec un accent sur l'oncologie, la gestion de la douleur et la thérapie des plaies.
InfuSystem Holdings, Inc. (NYSE American: INFU) gab seine Teilnahme an der Lytham Partners Fall 2024 Investorenkonferenz am 1. Oktober 2024 bekannt. Wichtige Führungskräfte, darunter CEO Richard DiIorio, Präsidentin und COO Carrie Lachance sowie CFO Barry Steele, werden anwesend sein. Ein live übertragenes Kamingespräch mit DiIorio ist für 15:30 Uhr ET angesetzt.
Der Webcast wird über die Website der Konferenz und die Investor Relations Seite von InfuSystem zugänglich sein. Das Management wird für Einzel- und Gruppengespräche mit Investoren zur Verfügung stehen. InfuSystem ist ein führender nationaler Anbieter von Gesundheitsdiensten, der unter zwei Plattformen tätig ist: Patient Services und Device Solutions. Das Unternehmen erleichtert die ambulante Versorgung für Hersteller von langlebigen medizinischen Geräten und Gesundheitsdienstleistern, mit einem Fokus auf Onkologie, Schmerzmanagement und Wundtherapie.
- None.
- None.
Fireside Chat to be held at 3:30pm ET
The webcasted fireside chat with CEO, Richard DiIorio will take place at 3:30pm ET on Tuesday, October 1, 2024. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/fall2024/ or on the Company’s website at https://ir.infusystem.com. The webcast will also be available for replay following the event.
Management will be available for one-on-one and group meetings with investors throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register for the event at https://lythampartners.com/fall2024invreg/.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. (NYSE American: INFU), is a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. INFU services are provided under a two-platform model. The first platform is Patient Services, providing the last-mile solution for clinic-to-home healthcare where the continuing treatment involves complex durable medical equipment and services. The Patient Services segment is comprised of Oncology, Pain Management and Wound Therapy businesses. The second platform, Device Solutions, supports the Patient Services platform and leverages strong service orientation to win incremental business from its direct payer clients. The Device Solutions segment is comprised of direct payer rentals, pump and consumable sales, and biomedical services and repair. Headquartered in
Forward-Looking Statements
Certain statements contained in this press release are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, such as statements relating to future actions, our share repurchase program and capital allocation strategy, business plans, strategic partnerships, growth initiatives, objectives and prospects, future operating or financial performance, guidance and expected new business relationships and the terms thereof (including estimated potential revenue under new or existing contracts). The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “goal,” “expect,” “strategy,” “future,” “likely,” variations of such words, and other similar expressions, as they relate to the Company, are intended to identify forward-looking statements. Forward-looking statements are subject to factors, risks and uncertainties that could cause actual results to differ materially, including, but not limited to, our ability to successfully execute on our growth initiatives and strategic partnerships, our ability to enter into definitive agreements for the new business relationships on expected terms or at all, our ability to generate estimated potential revenue amounts under new or existing contracts, our dependence on estimates of collectible revenue, potential litigation, changes in third-party reimbursement processes, changes in law, global financial conditions and recessionary risks, rising inflation and interest rates, supply chain disruptions, systemic pressures in the banking sector, including disruptions to credit markets, the Company’s ability to remediate its previously disclosed material weaknesses in internal control over financial reporting, contributions from acquired businesses or new business lines, products or services and other risk factors disclosed in the Company’s most recent annual report on Form 10-K and, to the extent applicable, quarterly reports on Form 10-Q. Our strategic partnerships are subject to similar factors, risks and uncertainties. All forward-looking statements made in this press release speak only as of the date hereof. We do not undertake any obligation to update any forward-looking statements to reflect future events or circumstances, except as required by law.
Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240927313184/en/
Joe Dorame, Joe Diaz & Robert Blum
Lytham Partners, LLC
602-889-9700
Source: InfuSystem Holdings, Inc.
FAQ
When is InfuSystem (INFU) participating in the Lytham Partners Fall 2024 Investor Conference?
What time is the webcasted fireside chat with InfuSystem's CEO scheduled for?
How can investors access the webcast of InfuSystem's (INFU) fireside chat?
What are the two main business platforms of InfuSystem (INFU)?
What services does InfuSystem's (INFU) Patient Services platform provide?
